Roche announces donation of essential medicines and diagnostic solutions to the people affected by the devastating earthquake in T ürkiye and Syria

Basel, 9 February 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced a donation to T ürkiye and Syria with a total value of 1.5 million Swiss Francs. This includes medicines, other products and financial support. Among others, we are committed to donating 120,000 packages of Rocephin, a critical antibiotic used to treat the symptoms of many kinds of bacterial infections and listed on the World Health Organization’s list of essential medicines. In addition we are committed to donating much needed supplies for diabetes management.Roche is deeply saddened by the devastating earthquake in T ürkiye and Syria on February 6, 2023 and is working diligently to support the people of Türkiye and Syria with medical products in accordance with Roche’s overall mission. Our thoughts are with the people affected by this tragedy and their families. We can confirm that all our employees are safe and accounted for. For those Roche colleagues who have lost their homes, Roche will provide temporary accommodation and will actively support them.About RocheFounded in 1896 in Basel, Switzerland, as one of the first industrial manufacturers of branded medicines, Roche has grown into the world ’s largest biotechnology company and the global leader in in-vitro diagnostics. The company pursues scientific excellence to discover and develop medicines and diagnostics for improving and saving the lives of people around the world. We are a pioneer in personalised healthcare and want to further...
Source: Roche Media News - Category: Pharmaceuticals Source Type: news